KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Globus Medical (GMED) Operating Expenses (2016 - 2025)

Globus Medical's Operating Expenses history spans 15 years, with the latest figure at $365.5 million for Q4 2025.

  • For Q4 2025, Operating Expenses rose 5000.04% year-over-year to $365.5 million; the TTM value through Dec 2025 reached $402.9 million, up 507.52%, while the annual FY2025 figure was $1.4 billion, 1962.83% up from the prior year.
  • Operating Expenses reached $365.5 million in Q4 2025 per GMED's latest filing, up from $6.3 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $365.5 million in Q4 2025 to a low of -$519.4 million in Q4 2023.
  • Average Operating Expenses over 5 years is $52.7 million, with a median of $117.8 million recorded in 2021.
  • Peak YoY movement for Operating Expenses: crashed 318.07% in 2022, then surged 5000.04% in 2025.
  • A 5-year view of Operating Expenses shows it stood at $170.0 million in 2021, then crashed by 318.07% to -$370.8 million in 2022, then crashed by 40.07% to -$519.4 million in 2023, then soared by 101.38% to $7.2 million in 2024, then soared by 5000.04% to $365.5 million in 2025.
  • Per Business Quant, the three most recent readings for GMED's Operating Expenses are $365.5 million (Q4 2025), $6.3 million (Q3 2025), and $22.4 million (Q2 2025).